Background: To explore the influence of the new stage and classification system based on the correlation between MRI and pathological features on the collapse, symptoms, and function of femoral head necrosis. Existing radiographic staging systems primarily evaluate structural changes and lesion morphology but provide limited information regarding intraosseous biological activity and pathological heterogeneity. Clinically, patients within the same ARCO stage often demonstrate markedly different symptoms, collapse patterns, and treatment responses, highlighting the need for an MRI-based classification reflecting underlying pathological status.
Methods: This retrospective study included 100 patients (200 hips) who were diagnosed with bilateral ONFH. According to the degree of fibrosis in the necrotic area in a mid-coronal section on hip MRI, the MRI stage of ONFH can be divided into three types. F1, borderline fibrosis (banded low signal); F2, partial fibrosis in the necrotic area (partial low signal); F3, global fibrosis in the necrotic area (global low signal). Based on the level of inflammatory response, the MRI classification of ONFH can be divided into four. E0, pathological stable type (no bone marrow edema and inflammatory); E1, partial edema of the femoral head and neck; E2, global edema of the femoral head and neck; E3, extensive edema of the proximal femur. The radiological evaluations were based on plain X-rays and MRI.
Results: There was a significant difference in the collapse rate between F1 (7.1%), F2 (66.3%), and F3 (92.1%) (p < 0.001). The collapse rate in E0 (11.1%), E1 (66.7%), E2 (85.3%), and E3 (77.8%) was significantly different (p < 0.001). There was also a significant difference in pain level and hip function between MRI stage and classification (p < 0.001). The later the stage, the higher the pain level, and similar results in hip functions. With the aggravation of bone marrow edema, the patient's pain level increases and hip function decreases. ROC analysis demonstrated that MRI stage based on fibrosis showed the highest discriminative ability for femoral head collapse (AUC = 0.819), compared with ARCO stage (AUC = 0.756) and MRI classification based on inflammatory response (AUC = 0.714). However, given the cross-sectional design and the potential for incorporation bias, these findings should be interpreted with caution.
Conclusion: MRI-based assessment of fibrosis extent and inflammatory activity provides additional information on intraosseous pathological status that is not captured by conventional radiographic stage systems and is significantly associated with femoral head collapse, pain, and hip function. This classification may have potential value for disease stratification and clinical assessment. However, its role in guiding treatment decisions and predicting longitudinal outcomes requires further validation in prospective studies.
| [1] |
J. Ma, J. Ge, F. Gao, et al., “The Role of Immune Regulatory Cells in Nontraumatic Osteonecrosis of the Femoral Head: A Retrospective Clinical Study,” BioMed Research International 2019 (2019): 1302015–1302017.
|
| [2] |
Z. Tan, Y. Wang, Y. Chen, et al., “The Dynamic Feature of Macrophage M1/M2 Imbalance Facilitates the Progression of Non-Traumatic Osteonecrosis of the Femoral Head,” Frontiers in Bioengineering and Biotechnology 10 (2022): 912133.
|
| [3] |
D. Petek, D. Hannouche, and D. Suva, “Osteonecrosis of the Femoral Head: Pathophysiology and Current Concepts of Treatment,” EFORT Open Reviews 4, no. 3 (2019): 85–97.
|
| [4] |
C. Chang, A. Greenspan, and M. E. Gershwin, “The Pathogenesis, Diagnosis and Clinical Manifestations of Steroid-Induced Osteonecrosis,” Journal of Autoimmunity 110 (2020): 102460.
|
| [5] |
T. Shoji, T. Yamasaki, Y. Ota, H. Saka, Y. Yasunaga, and N. Adachi, “Intra-Articular Pathology Affects Outcomes After Joint Preserving Surgery for Osteonecrosis of the Femoral Head,” International Orthopaedics 44, no. 7 (2020): 1295–1303.
|
| [6] |
Y. Chen, Y. Miao, K. Liu, et al., “Evolutionary Course of the Femoral Head Osteonecrosis: Histopathological – Radiologic Characteristics and Clinical Stage Systems,” Journal of Orthopaedic Translation 32 (2022): 28–40.
|
| [7] |
Y. Osawa, Y. Takegami, D. Kato, M. Okamoto, H. Iida, and S. Imagama, “Hip Function in Patients Undergoing Conservative Treatment for Osteonecrosis of the Femoral Head,” International Orthopaedics 47 (2022): 89–94.
|
| [8] |
Q. Y. Zhang, Z. R. Li, F. Q. Gao, and W. Sun, “Pericollapse Stage of Osteonecrosis of the Femoral Head: A Last Chance for Joint Preservation,” Chinese Medical Journal 131, no. 21 (2018): 2589–2598.
|
| [9] |
M. D. Murphey, K. L. Foreman, M. K. Klassen-Fischer, M. G. Fox, E. M. Chung, and M. J. Kransdorf, “From the Radiologic Pathology Archives Imaging of Osteonecrosis: Radiologic-Pathologic Correlation,” Radiographics 34, no. 4 (2014): 1003–1028.
|
| [10] |
T. Yamamoto, R. Schneider, and P. G. Bullough, “Subchondral Insufficiency Fracture of the Femoral Head: Histopathologic Correlation With Mri,” Skeletal Radiology 30, no. 5 (2001): 247–254.
|
| [11] |
L. B. Hu, Z. G. Huang, H. Y. Wei, W. Wang, A. Ren, and Y. Y. Xu, “Osteonecrosis of the Femoral Head: Using Ct, Mri and Gross Specimen to Characterize the Location, Shape and Size of the Lesion,” British Journal of Radiology 88, no. 1046 (2015): 20140508.
|
| [12] |
S. Shi, P. Luo, L. Sun, et al., “Analysis of Mr Signs to Distinguish Between Arco Stages 2 and 3a in Osteonecrosis of the Femoral Head,” Journal of Magnetic Resonance Imaging 55, no. 2 (2022): 610–617.
|
| [13] |
N. S. Adapala, R. Yamaguchi, M. Phipps, O. Aruwajoye, and H. K. W. Kim, “Necrotic Bone Stimulates Proinflammatory Responses in Macrophages Through the Activation of Toll-Like Receptor 4,” American Journal of Pathology 186, no. 11 (2016): 2987–2999.
|
| [14] |
L. Molfetta, A. Florian, G. Saviola, and B. Frediani, “Bone Marrow Edema: Pathogenetic Features,” La Clinica Terapeutica 173, no. 5 (2022): 434–439.
|
| [15] |
M. Ma, Z. Tan, W. Li, H. Zhang, Y. Liu, and C. Yue, “Osteoimmunology and Osteonecrosis of the Femoral Head,” Bone & Joint Research 11, no. 1 (2022): 26–28.
|
| [16] |
T. Yu, L. Xie, Z. Zhang, X. Ke, and Y. Liu, “Prediction of Osteonecrosis Collapse of the Femoral Head Based on the Proportion of the Proximal Sclerotic Rim,” International Orthopaedics 39, no. 6 (2015): 1045–1050.
|
| [17] |
L. Chen, G. Hong, B. Fang, et al., “Predicting the Collapse of the Femoral Head due to Osteonecrosis: From Basic Methods to Application Prospects,” Journal of Orthopaedic Translation 11 (2017): 62–72.
|
| [18] |
C. Wang, H. Meng, Y. Wang, et al., “Analysis of Early Stage Osteonecrosis of the Human Femoral Head and the Mechanism of Femoral Head Collapse,” International Journal of Biological Sciences 14, no. 2 (2018): 156–164.
|
| [19] |
A. S. Brody, M. Strong, G. Babikian, D. E. Sweet, F. G. Seidel, and J. P. Kuhn, “John Caffey Award Paper. Avascular Necrosis: Early Mr Imaging and Histologic Findings in a Canine Model,” American Journal of Roentgenology 157, no. 2 (1991): 341–345.
|
| [20] |
H. Plenk, Jr., M. Gstettner, K. Grossschmidt, M. Breitenseher, M. Urban, and S. Hofmann, “Magnetic Resonance Imaging and Histology of Repair in Femoral Head Osteonecrosis,” Clinical Orthopaedics and Related Research 386 (2001): 42–53.
|
| [21] |
W. Jianchuan, Y. Lei, W. Benjie, and Z. Dewei, “Study on Correlation Between Bone Marrow Edema, Stage of Necrosis and Area Ratio of Necrosis With the Hip Pain Grading in Nontraumatic Osteonecrosis of the Femoral Head,” Open Medicine 10, no. 1 (2015): 440–444.
|
| [22] |
S. Ikemura, G. Motomura, R. Yamaguchi, et al., “The Influence of Bone Marrow Edema for the Assessment of the Boundaries of Necrotic Lesions in Patients With Osteonecrosis of the Femoral Head,” Scientific Reports 12, no. 1 (2022): 18649.
|
| [23] |
D. Zou, K. Zhang, Y. Yang, et al., “Th17 and Il-17 Exhibit Higher Levels in Osteonecrosis of the Femoral Head and Have a Positive Correlation With Severity of Pain,” Endokrynologia Polska 69, no. 3 (2018): 283–290.
|
| [24] |
K. H. Koo, I. O. Ahn, R. Kim, et al., “Bone Marrow Edema and Associated Pain in Early Stage Osteonecrosis of the Femoral Head: Prospective Study With Serial Mr Images,” Radiology 213, no. 3 (1999): 715–722.
|
| [25] |
S. Iida, Y. Harada, K. Shimizu, et al., “Correlation Between Bone Marrow Edema and Collapse of the Femoral Head in Steroid-Induced Osteonecrosis,” American Journal of Roentgenology 174, no. 3 (2000): 735–743.
|
| [26] |
F. Sadile, A. Bernasconi, F. Carbone, F. Lintz, and G. Mansueto, “Histological Fibrosis May Predict the Failure of Core Decompression in the Treatment of Osteonecrosis of the Femoral Head,” International Journal of Surgery 44 (2017): 303–308.
|
| [27] |
R. Meier, T. M. Kraus, C. Schaeffeler, et al., “Bone Marrow Oedema on Mr Imaging Indicates Arco Stage 3 Disease in Patients With Avn of the Femoral Head,” European Radiology 24, no. 9 (2014): 2271–2278.
|
| [28] |
A. J. Theruvath, P. A. Sukerkar, S. Bao, et al., “Bone Marrow Oedema Predicts Bone Collapse in Paediatric and Adolescent Leukaemia Patients With Corticosteroid-Induced Osteonecrosis,” European Radiology 28, no. 1 (2018): 410–417.
|
Rights & permissions
2026 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.
PDF
(834KB)
